Disambiguation evidence for CD19 via surface form

"CD19"

Triples (4)

Triples where some other subject referred to this entity as "CD19".

Juno Therapeutics → therapeuticTarget →
"CD19"
↳ resolves to CD19
ⓘ
Kymriah → molecularTarget →
"CD19"
↳ resolves to CD19
ⓘ
chronic lymphocytic leukemia → hasImmunophenotypeMarker →
"CD19"
↳ resolves to CD19
ⓘ
CD21 → formsComplexWith →
"CD19"
↳ resolves to CD19
ⓘ